/ RLMD
Why Is RLMD Stock Surging Premarket? NDV-01 Trial Update and $160M PIPE Deal
Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million PIPE financing.
March 09, 2026Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million PIPE financing.
March 09, 2026